A systems approach to designing effective clinical trials using simulations

Vincent A. Fusaro, Prasad Patil, Chih Lin Chi, Charles F. Contant, Peter J. Tonellato

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Background: Pharmacogenetics in warfarin clinical trials have failed to show a significant benefit in comparison with standard clinical therapy. This study demonstrates a computational framework to systematically evaluate preclinical trial design of target population, pharmacogenetic algorithms, and dosing protocols to optimize primary outcomes. Methods and Results: We programmatically created an end-to-end framework that systematically evaluates warfarin clinical trial designs. The framework includes options to create a patient population, multiple dosing strategies including genetic-based and nongenetic clinical-based, multiple-dose adjustment protocols, pharmacokinetic/pharmacodynamics modeling and international normalization ratio prediction, and various types of outcome measures. We validated the framework by conducting 1000 simulations of the Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin (CoumaGen) clinical trial primary end points. The simulation predicted a mean time in therapeutic range of 70.6% and 72.2% (P=0.47) in the standard and pharmacogenetic arms, respectively. Then, we evaluated another dosing protocol under the same original conditions and found a significant difference in the time in therapeutic range between the pharmacogenetic and standard arm (78.8% versus 73.8%; P=0.0065), respectively. Conclusions: We demonstrate that this simulation framework is useful in the preclinical assessment phase to study and evaluate design options and provide evidence to optimize the clinical trial for patient efficacy and reduced risk.

Original languageEnglish (US)
Pages (from-to)517-526
Number of pages10
JournalCirculation
Volume127
Issue number4
DOIs
StatePublished - Jan 29 2013

Keywords

  • Bioinformatics
  • Clinical trials
  • Individualized medicine
  • Modeling
  • Pharmacogenetics
  • Simulations
  • Warfarin

Fingerprint Dive into the research topics of 'A systems approach to designing effective clinical trials using simulations'. Together they form a unique fingerprint.

Cite this